ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 4 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $958,464 | -15.5% | 26,975 | +10.9% | 0.00% | 0.0% |
| Q2 2023 | $1,133,962 | +4.8% | 24,313 | -10.0% | 0.00% | 0.0% |
| Q1 2023 | $1,082,172 | -67.0% | 27,012 | -62.7% | 0.00% | -75.0% |
| Q4 2022 | $3,277,891 | +617.3% | 72,480 | +568.1% | 0.00% | +300.0% |
| Q3 2022 | $457,000 | -43.6% | 10,849 | -21.0% | 0.00% | 0.0% |
| Q2 2022 | $810,000 | -24.2% | 13,733 | -6.4% | 0.00% | 0.0% |
| Q1 2022 | $1,069,000 | +95.4% | 14,668 | +127.9% | 0.00% | 0.0% |
| Q4 2021 | $547,000 | -10.5% | 6,437 | -5.8% | 0.00% | 0.0% |
| Q3 2021 | $611,000 | -26.7% | 6,834 | -21.2% | 0.00% | 0.0% |
| Q2 2021 | $833,000 | +73.5% | 8,672 | +106.0% | 0.00% | 0.0% |
| Q1 2021 | $480,000 | -65.6% | 4,209 | -57.7% | 0.00% | -50.0% |
| Q4 2020 | $1,397,000 | +213.9% | 9,962 | +89.3% | 0.00% | +100.0% |
| Q3 2020 | $445,000 | -59.6% | 5,263 | -79.3% | 0.00% | -50.0% |
| Q4 2019 | $1,102,000 | -9.4% | 25,424 | -10.6% | 0.00% | 0.0% |
| Q3 2019 | $1,217,000 | +471.4% | 28,448 | +582.7% | 0.00% | – |
| Q1 2018 | $213,000 | -64.9% | 4,167 | -51.8% | 0.00% | -100.0% |
| Q4 2016 | $607,000 | +177.2% | 8,645 | +303.8% | 0.00% | – |
| Q2 2015 | $219,000 | – | 2,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |